Quanterix Corporation announced the appointment of Ivana Magovčević-Liebisch, Ph.D., J.D. to its Board of Directors on September 17, 2024. Dr. Magovčević-Liebisch brings over 25 years of biopharmaceutical industry experience to the role.
Her background includes founding Vigil Neuroscience, Inc., where she serves as President and Chief Executive Officer, and previously holding executive positions at Ipsen and Teva Pharmaceutical Industries Ltd. She holds a Ph.D. in Genetics from Harvard University and a J.D. in High Technology Law from Suffolk University Law School.
CEO Masoud Toloue stated that Dr. Magovčević-Liebisch's business acumen and leadership experience will be invaluable as Quanterix expands its existing biomarker partnerships with pharma and biotech, and moves further into clinical diagnostics.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.